Method and kit for determining the probability that a patient will develop a severe case of dengue
US10281470B2 · kind B2 · utility
0Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 6, 2018 |
| Grant date | May 7, 2019 |
| Priority date | — |
| Expiry date | Mar 6, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A kit for determining whether a patient will develop severe dengue includes a binding partner for olfactomedin 4 and a binding partner for at least one member selected from the group consisting of dengue virus NS1 protein, platelet factor 4, and α2-macroglobulin. The kit may further include a label reagent capable of generating a detectable signal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.